Learn More
Abcam C16, PKR inhibitor, 25MG
Supplier: Abcam AB14459525MG
MW 268.3 Da, Purity >98%. Specific double-stranded RNA-dependent protein kinase (PKR) inhibitor. Prevents PKR-induced neuronal loss in vivo. Inhibits apoptotic PKR/eIF2α signaling pathway in vivo. Neuroprotective, antitumor and anti-inflammatory agent. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.